Indolent B-Cell Non-Hodgkin Lymphoma
generalA B-cell non-Hodgkin lymphoma with an indolent clinical course. Representative examples include grade 1 and grade 2 follicular lymphoma, marginal zone lymphoma, and lymphoplasmacytic lymphoma.
8
Centers
8
Active Trials
—
Cancer Funding
Top Centers for Indolent B-Cell Non-Hodgkin Lymphoma(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 56.2 |
| 2 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 56.2 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 56.2 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 56.2 |
| 5 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 56.2 |
| 6 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 56.2 |
| 7 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 56.2 |
| 8 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 56.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →